Immunotherapy is safe for people with Type 1 Diabetes: Study

Immunotherapy is safe for people with Type 1 Diabetes: Study

An immune system therapy can help diabetic people with type-1 of the disease by keeping insulin production steady, a small clinical trial by a team of British researchers showed.

The researchers said the therapy, which is similar to an allergy shot in the manner it works, can keep people with type-1 diabetes safe.

Dr. Mark Peakman, a professor of clinical immunology at King's College London in England, said they found that the immunotherapy had the potential to stop the attacks on beta cells that make insulin.

Speaking on the topic, Dr. Peakman said, “Type 1 diabetes comes about when the immune system inadvertently and irreparably damages beta cells that make insulin … We have learned that immune attacks like this can be suppressed by immune cells called T-regs (regulatory T cells).”

The immunotherapy literally re-educates the body’s immune system, and teaches the cells that they should not attack the beta cells.

The researchers reported their findings in the most recent (August 9th) edition of the journal Science Translational Medicine.

Category: 
Location: